Business of Medicine
Commentary
Tackling Sexism in Medicine
Dr. Kathrin LaFaver and Dr. Elizabeth Loder discuss sexism encountered in medicine.
Latest News
Novel Clinic Resulted in ‘Impressive’ Outcomes for Patients With Moderate to Severe Eczema
“As clinicians we tend to remember the ‘tough cases,’ and it was tremendous to see the impact and utility of the clinic,” Dr. Lawrence Eichenfield...
Managing Your Practice
Why Don’t Physicians Call In Sick?
We can work to overcome this institutional taboo against staying home when we do get sick. Work out a system of mutual coverage for such...
The Optimized Doctor
How much would you bet on a diagnosis?
For much of the work we do, precise likelihoods aren't critical. Yet, it can be important in decision making and in discussing probabilities, such...
Feature
Oncologists Sound the Alarm About Rise of White Bagging
For years, oncologist John DiPersio had faced frustrating encounters with insurers that cover medications only through a process called white...
Latest News
New Federal Rule for Prior Authorizations a ‘Major Win’ for Patients, Doctors
A long-awaited federal rule on prior authorization was hailed by physicians’ groups for streamlining burdensome procedures and forcing insurers to...
Feature
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.
Latest News
Time Off Isn’t Really Off-Time for Most Physicians, Study Finds
The majority of physicians still did work-related tasks while on vacation last year, according to study.
Latest News
Panel Recommends Small Bump in 2025 Medicare Physician Pay
The MedPAC vote comes amid continuing uncertainty about how much the federal government will actually pay clinicians this year through the...
Pearl of the Month
Pet Peeves About the State of Primary Care – Part 2
Physicians note the increase in the number of hospital administrators, specialists who refer patients away from primary care, insurance carriers...
Latest News
DSM-5-TR Panel Members Received $14M in Undisclosed Industry Funding
Contributors to the DSM-5-TR received more than $14 million in undisclosed industry funding.